(S)-Epichlorohydrin (BioDeep_00000645560)
代谢物信息卡片
(S)-(+)-Epichlorhydrin
化学式: C3H5ClO (92.00289100000002)
中文名称: (S)-(+)-环氧氯丙烷, （S） -表氯醇
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1C(O1)CCl
InChI: InChI=1S/C3H5ClO/c4-1-3-2-5-3/h3H,1-2H2/t3-/m1/s1
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Susan C Schiavi, Wen Tang, Christina Bracken, Stephen P O'Brien, Wenping Song, Joseph Boulanger, Susan Ryan, Lucy Phillips, Shiguang Liu, Cynthia Arbeeny, Steven Ledbetter, Yves Sabbagh. Npt2b deletion attenuates hyperphosphatemia associated with CKD.
Journal of the American Society of Nephrology : JASN.
2012 Oct; 23(10):1691-700. doi:
10.1681/asn.2011121213. [PMID: 22859851] - Sonal Amit, Asha Agarwal, Anand Nigam, Yashwant Kumar Rao. Recurrent hyperphosphatemic tumoural calcinosis.
BMJ case reports.
2012 Sep; 2012(?):. doi:
10.1136/bcr-2012-006681. [PMID: 23010461] - Farrokhlagha Ahmadi, Fatemeh Shamekhi, Mahbob Lessan-Pezeshki, Mohammad Reza Khatami. Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
2012 Sep; 23(5):934-8. doi:
10.4103/1319-2442.100865. [PMID: 22982903] - Geoffrey A Block, David C Wheeler, Martha S Persky, Bryan Kestenbaum, Markus Ketteler, David M Spiegel, Matthew A Allison, John Asplin, Gerard Smits, Andrew N Hoofnagle, Laura Kooienga, Ravi Thadhani, Michael Mannstadt, Myles Wolf, Glenn M Chertow. Effects of phosphate binders in moderate CKD.
Journal of the American Society of Nephrology : JASN.
2012 Aug; 23(8):1407-15. doi:
10.1681/asn.2012030223. [PMID: 22822075] - Takayuki Hamano. [Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD].
Clinical calcium.
2012 Jul; 22(7):1043-9. doi:
clica120710431049. [PMID: 22750937] - Sarah P Hudson, Eleanor Owens, Helen Hughes, Peter McLoughlin. Enhancement and restriction of chain motion in polymer networks.
International journal of pharmaceutics.
2012 Jul; 430(1-2):34-41. doi:
10.1016/j.ijpharm.2012.03.045. [PMID: 22486959] - Roberto S Kalil, Michael Flanigan, William Stanford, William G Haynes. Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study.
Clinical nephrology.
2012 Jul; 78(1):1-9. doi:
10.5414/cn106830. [PMID: 22732331] - Giuseppe Rombolà, Francesco Londrino, Valentina Corbani, Valeria Falqui, Michela Ardini, Tito Zattera. Lanthanum carbonate: a postmarketing observational study of efficacy and safety.
Journal of nephrology.
2012 Jul; 25(4):490-6. doi:
10.5301/jn.5000118. [PMID: 22476966] - Helen Vlassara, Jaime Uribarri, Weijing Cai, Susan Goodman, Renata Pyzik, James Post, Fabrizio Grosjean, Mark Woodward, Gary E Striker. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN.
2012 Jun; 7(6):934-42. doi:
10.2215/cjn.12891211. [PMID: 22461535] - Beryl Lai, Matthew J Cervelli. Effect of gastric acid suppression with pantoprazole on the efficacy of sevelamer hydrochloride as a phosphate binder in haemodialysis patients: a pilot study.
Nephrology (Carlton, Vic.).
2012 May; 17(4):402-6. doi:
10.1111/j.1440-1797.2012.01583.x. [PMID: 22329674] - Martin Hanus, Eugene Zhorov, Deborah Brommage, Melissa Plone, Stephen Randall Holmes-Farley. Assessment of phosphate binding by sevelamer carbonate powder for oral suspension mixed in foods.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
2012 May; 39(3):239-43, 255. doi:
NULL. [PMID: 22866363] - Biagio Di Iorio, Antonio Bellasi, Domenico Russo. Mortality in kidney disease patients treated with phosphate binders: a randomized study.
Clinical journal of the American Society of Nephrology : CJASN.
2012 Mar; 7(3):487-93. doi:
10.2215/cjn.03820411. [PMID: 22241819] - Ryota Ikee, Masataka Tsunoda, Naomi Sasaki, Naritsugu Sato, Nobuo Hashimoto. Potential influence of sevelamer hydrochloride on responsiveness to erythropoiesis-stimulating agents in haemodialysis patients.
Nephrology (Carlton, Vic.).
2012 Mar; 17(3):225-9. doi:
10.1111/j.1440-1797.2011.01545.x. [PMID: 22117587] - Paweena Susantitaphong, Bertrand L Jaber. Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2012 Feb; 59(2):165-7. doi:
10.1053/j.ajkd.2011.12.001. [PMID: 22243944] - Mahmut Ilker Yilmaz, Alper Sonmez, Mutlu Saglam, Halil Yaman, Selim Kilic, Tayfun Eyileten, Kayser Caglar, Yusuf Oguz, Abdulgaffar Vural, Mujdat Yenicesu, Francesca Mallamaci, Carmine Zoccali. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2012 Feb; 59(2):177-85. doi:
10.1053/j.ajkd.2011.11.007. [PMID: 22137672] - Igor G Nikolov, Nobuhiko Joki, Thao Nguyen-Khoa, Ida Chiara Guerrera, Julien Maizel, Joyce Benchitrit, Luciene Machado dos Reis, Aleksander Edelman, Bernard Lacour, Vanda Jorgetti, Tilman B Drüeke, Ziad A Massy. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2012 Feb; 27(2):505-13. doi:
10.1093/ndt/gfr254. [PMID: 21705467] - Atsushi Hosomi, Takeo Nakanishi, Takuya Fujita, Ikumi Tamai. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2.
PloS one.
2012; 7(2):e30456. doi:
10.1371/journal.pone.0030456. [PMID: 22348008] - João M Frazão, Teresa Adragão. Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects.
Nephron. Clinical practice.
2012; 120(2):c108-19. doi:
10.1159/000337087. [PMID: 22555359] - Ming Zeng, Xiaoyun Wang, Xiaobing Wang, Xiufen Zhao. Effects of phosphonoformic acid and renagel on renal type IIa sodium-dependent phosphate cotransporter mRNA expression in hyperphosphatemia rats.
Renal failure.
2012; 34(3):358-63. doi:
10.3109/0886022x.2011.647341. [PMID: 22260362] - Michael Pennick, Lynne Poole, Kerry Dennis, Michael Smyth. Lanthanum carbonate reduces urine phosphorus excretion: evidence of high-capacity phosphate binding.
Renal failure.
2012; 34(3):263-70. doi:
10.3109/0886022x.2011.649657. [PMID: 22250993] - A K Guddati, Z Zafar, J T Cheng, S Mohan. Treatment of gabapentin-induced myoclonus with continuous renal replacement therapy.
Indian journal of nephrology.
2012 Jan; 22(1):59-61. doi:
10.4103/0971-4065.83744. [PMID: 22279347] - Marion Morena, Isabelle Jaussent, Aurore Halkovich, Anne-Marie Dupuy, Anne-Sophie Bargnoux, Leila Chenine, Hélène Leray-Moragues, Kada Klouche, Hélène Vernhet, Bernard Canaud, Jean-Paul Cristol. Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.
PloS one.
2012; 7(5):e36175. doi:
10.1371/journal.pone.0036175. [PMID: 22567137] - Emilio González-Parra, Carolina Gracia-Iguacel, Jesús Egido, Alberto Ortiz. Phosphorus and nutrition in chronic kidney disease.
International journal of nephrology.
2012; 2012(?):597605. doi:
10.1155/2012/597605. [PMID: 22701173] - Hisae Tanaka, Hirotaka Komaba, Masahiro Koizumi, Takatoshi Kakuta, Masafumi Fukagawa. Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2012 Jan; 22(1):98-101. doi:
10.1053/j.jrn.2011.10.031. [PMID: 22200424] - Peng Hu, Qiang Xuan, Bo Hu, Ling Lu, Jing Wang, Yuan Han Qin. Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
International journal of biological sciences.
2012; 8(5):663-71. doi:
10.7150/ijbs.3886. [PMID: 22606047] - Fellype Carvalho Barreto, Rodrigo Azevedo de Oliveira, Rodrigo Bueno Oliveira, Vanda Jorgetti. Pharmacotherapy of chronic kidney disease and mineral bone disorder.
Expert opinion on pharmacotherapy.
2011 Dec; 12(17):2627-40. doi:
10.1517/14656566.2011.626768. [PMID: 22017388] - Haesuk Park, Karen L Rascati, Michael S Keith, Paul Hodgkins, Michael Smyth, David Goldsmith, Ron Akehurst. Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
2011 Dec; 14(8):1002-9. doi:
10.1016/j.jval.2011.05.043. [PMID: 22152168] - A Marinelli, L Orlandi, G Stivali. C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis.
Clinical nephrology.
2011 Dec; 76(6):425-34. doi:
10.5414/cn107003. [PMID: 22105444] - Leonardo Lucchi, Chiara Carboni, Lucia Stipo, Vittoria Malaguti, Federica Ferrari, Romina Graziani, Silvia Arletti, Catia Graziosi. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
Artificial organs.
2011 Dec; 35(12):1186-93. doi:
10.1111/j.1525-1594.2011.01270.x. [PMID: 21848793] - Ranjani N Moorthi, Sharon M Moe. CKD-mineral and bone disorder: core curriculum 2011.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2011 Dec; 58(6):1022-36. doi:
10.1053/j.ajkd.2011.08.009. [PMID: 22018457] - Corisande Baldwin, Myriam Farah, Marianna Leung, Paul Taylor, Ronald Werb, Mercedeh Kiaii, Adeera Levin. Multi-intervention management of calciphylaxis: a report of 7 cases.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2011 Dec; 58(6):988-91. doi:
10.1053/j.ajkd.2011.06.022. [PMID: 21872378] - Ezio Movilli, Corrado Camerini, Paola Gaggia, Patrizia Poiatti, Alessandra Pola, Battista Fabio Viola, Roberto Zubani, Guido Jeannin, Giovanni Cancarini. Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2011 Dec; 26(12):4032-7. doi:
10.1093/ndt/gfr179. [PMID: 21555393] - Sharon M Moe, J Scott Radcliffe, Kenneth E White, Vincent H Gattone, Mark F Seifert, Xianming Chen, Blaire Aldridge, Neal X Chen. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2011 Nov; 26(11):2672-81. doi:
10.1002/jbmr.485. [PMID: 21826734] - Jin-Bor Chen, Shou-Shan Chiang, Hung-Chun Chen, Seiichi Obayashi, Masaki Nagasawa, J Mark Hexham, Alison Balfour, Guido Junge, Takashi Akiba, Masafumi Fukagawa. Efficacy and safety of SBR759, a novel calcium-free, iron(III)-based phosphate binder, in Asian patients undergoing hemodialysis: A 12-week, randomized, open-label, dose-titration study versus sevelamer hydrochloride.
Nephrology (Carlton, Vic.).
2011 Nov; 16(8):743-50. doi:
10.1111/j.1440-1797.2011.01509.x. [PMID: 21854503] - Nicholas A Gray, Rathika Krishnasamy, Deepak L Vardesh, Peter R Hollett, Chris M Anstey. Impact of non-traditional phosphate binders and cinacalcet on haemodialysis patient biochemistry, pill burden and cost.
Nephrology (Carlton, Vic.).
2011 Nov; 16(8):688-96. doi:
10.1111/j.1440-1797.2011.01482.x. [PMID: 21649793] - M Senatore, G Coppolino, T Papalia, R Greco, D Lofaro, R Bonofiglio. Does concomitant administration of sevelamer hydrochloride and lanthanum carbonate modify the control of phosphatemia?.
European review for medical and pharmacological sciences.
2011 Nov; 15(11):1352-4. doi:
NULL. [PMID: 22195373] - Masaru Nakayama, Yoriko Ura, Masaharu Nagata, Yasushi Okada, Yoko Sumida, Kanako Nishida, Hirofumi Ikeda, Yoshiki Kaizu. Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: a cohort study.
BMC nephrology.
2011 Oct; 12(?):56. doi:
10.1186/1471-2369-12-56. [PMID: 21999942] - J Vasantha, P Soundararajan, N Vanitharani, G Kannan, P Thennarasu, G Neenu, C Umamaheswara Reddy. Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis.
Indian journal of nephrology.
2011 Oct; 21(4):245-9. doi:
10.4103/0971-4065.83735. [PMID: 22022084] - M Adachi, T Miyoshi, N Shiraishi, H Shimada, S Sakaguchi, K Tomita, K Kitamura. A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism.
Clinical nephrology.
2011 Oct; 76(4):266-72. doi:
10.5414/cn106595. [PMID: 21955861] - Sophie Brunner-Ziegler, Barbara Fröschl, Cora Hiebinger, Johannes Zsifkovits. Effectiveness and cost-efficacy of phosphate binders in hemodialysis.
Annals of nutrition & metabolism.
2011 Oct; 58(4):315-9. doi:
10.1159/000331988. [PMID: 21986491] - Nirupama Vemuri, Michael F Michelis, Albert Matalon. Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study.
BMC nephrology.
2011 Sep; 12(?):49. doi:
10.1186/1471-2369-12-49. [PMID: 21962172] - Alastair J Hutchison, Craig P Smith, Paul E C Brenchley. Pharmacology, efficacy and safety of oral phosphate binders.
Nature reviews. Nephrology.
2011 Sep; 7(10):578-89. doi:
10.1038/nrneph.2011.112. [PMID: 21894188] - Shahrzad Ossareh. Vascular calcification in chronic kidney disease: mechanisms and clinical implications.
Iranian journal of kidney diseases.
2011 Sep; 5(5):285-99. doi:
. [PMID: 21876304] - Juan F Navarro-González, Carmen Mora-Fernández, Mercedes Muros de Fuentes, Javier Donate-Correa, Violeta Cazaña-Pérez, Javier García-Pérez. Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN.
2011 Sep; 6(9):2272-9. doi:
10.2215/cjn.01650211. [PMID: 21784820] - Jwa-Kyung Kim, Sung Jin Moon, Hyeong Cheon Park, Jae Sung Lee, Soung Rok Sim, Sung Chang Bae, Sung Kyu Ha. Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis.
The Korean journal of internal medicine.
2011 Sep; 26(3):320-7. doi:
10.3904/kjim.2011.26.3.320. [PMID: 22016593] - Nessrine Akasbi, Tarik Sqalli Houssaini, Samira Rabhi, Mariam Lahlou, Amal Boukhrissa, Latifa Tahiri, Chakib El Maaroufi, Rhizlane Berrady, Taoufik Harzy, Wafaa Bono. Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
2011 Aug; 17(5):272-4. doi:
10.1097/rhu.0b013e3182288acd. [PMID: 21778901] - Thomas Plagemann, Anne Prenzler, Thomas Mittendorf. Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia.
Health economics review.
2011 Jul; 1(1):1. doi:
10.1186/2191-1991-1-1. [PMID: 22828213] - Piergiorgio Bolasco. [Effect of non-calcium-based phosphate binders on vascular calcifications in patients on hemodialysis: clinical experience and hypotheses].
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.
2011 Jul; 28(4):357. doi:
NULL. [PMID: 21809303] - David W Mudge, David W Johnson, Carmel M Hawley, Scott B Campbell, Nicole M Isbel, Carolyn L van Eps, James J B Petrie. Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?.
BMC nephrology.
2011 May; 12(?):20. doi:
10.1186/1471-2369-12-20. [PMID: 21569446] - Patrick Martin, Phillip Wang, Antoine Robinson, Lynne Poole, Jeffrey Dragone, Michael Smyth, Raymond Pratt. Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2011 May; 57(5):700-6. doi:
10.1053/j.ajkd.2010.11.028. [PMID: 21354682] - Linda Noto. Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2011 May; 21(3):277-82. doi:
10.1053/j.jrn.2010.04.007. [PMID: 20598905] - David Pierce, Stuart Hossack, Lynne Poole, Antoine Robinson, Heather Van Heusen, Patrick Martin, Michael Smyth. The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2011 May; 26(5):1615-21. doi:
10.1093/ndt/gfq598. [PMID: 20921291] - S D Soroka, K M Beard, D C Mendelssohn, S H Cournoyer, G A Da Roza, D F Geary. Mineral metabolism management in Canadian peritoneal dialysis patients.
Clinical nephrology.
2011 May; 75(5):410-5. doi:
10.5414/cnp75410. [PMID: 21543020] - Keith Hruska, Suresh Mathew, Richard Lund, Yifu Fang, Toshifumi Sugatani. Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?.
Kidney international. Supplement.
2011 Apr; ?(121):S9-13. doi:
NULL. [PMID: 21346719] - Goce Spasovski, Raymond Vanholder. Is combined calcium/magnesium phosphate binder really noninferior to sevelamer hydrochloride?.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2011 Apr; 26(4):1442-3; author reply 1443. doi:
10.1093/ndt/gfq778. [PMID: 21339309] - Shunsuke Goto, Kunihiko Yoshiya, Tomoyuki Kita, Hideki Fujii, Masafumi Fukagawa. Uremic toxins and oral adsorbents.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
2011 Apr; 15(2):132-4. doi:
10.1111/j.1744-9987.2010.00891.x. [PMID: 21426503] - Julia Kerschbaum, Paul König, Johann Hausdorfer, Gert Mayer, Michael Rudnicki. Sevelamer use and incidence of peritonitis in peritoneal dialysis.
Wiener klinische Wochenschrift.
2011 Apr; 123(7-8):204-8. doi:
10.1007/s00508-011-1551-1. [PMID: 21442203] - F Summaria, S Manca Di Villahermosa, M Tedesco, M Lonzi, G Colarieti, M G Chamoun, M Taccone Gallucci. Cardiovascular outcome in asymptomatic hemodialysis patients submitted to aggressive medical therapy: results of a four-year follow-up.
Minerva cardioangiologica.
2011 Apr; 59(2):121-6. doi:
NULL. [PMID: 21242949] - Takatoshi Kakuta, Reika Tanaka, Toru Hyodo, Hajime Suzuki, Genta Kanai, Mikako Nagaoka, Hiroo Takahashi, Nobuhito Hirawa, Yoichi Oogushi, Toshio Miyata, Hiroyuki Kobayashi, Masafumi Fukagawa, Akira Saito. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2011 Mar; 57(3):422-31. doi:
10.1053/j.ajkd.2010.10.055. [PMID: 21239096] - Kristin Veighey, John Booth, Andrew Davenport. Does the choice of phosphate binder affect trace element levels in chronic kidney disease patients treated by regular haemodialysis?.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2011 Mar; 26(3):1006-10. doi:
10.1093/ndt/gfq520. [PMID: 20736253] - Sushil Razdan, Kk Pandita, Vanilla Chopra, Sanjay Koul. New-onset headache in an elderly man with uremia that improved only after correction of hyperphosphatemia ('uremic headache'): a case report.
Journal of medical case reports.
2011 Feb; 5(?):77. doi:
10.1186/1752-1947-5-77. [PMID: 21349164] - Sankar D Navaneethan, Suetonia C Palmer, Mariacristina Vecchio, Jonathan C Craig, Grahame J Elder, Giovanni Fm Strippoli. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.
The Cochrane database of systematic reviews.
2011 Feb; ?(2):CD006023. doi:
10.1002/14651858.cd006023.pub2. [PMID: 21328279] - Panagiotis Pateinakis, Aikaterini Papagianni. Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.
International journal of nephrology.
2011 Feb; 2011(?):938651. doi:
10.4061/2011/938651. [PMID: 21331317] - Colin D Chue, Jonathan N Townend, Richard P Steeds, Charles J Ferro. Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial.
Trials.
2011 Feb; 12(?):30. doi:
10.1186/1745-6215-12-30. [PMID: 21288351] - Matthew A Weir, Arsh K Jain, Tara Gomes, David N Juurlink, Muhammad Mamdani, Lihua Li, Amit X Garg. Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2011 Feb; 57(2):357-9. doi:
10.1053/j.ajkd.2010.09.025. [PMID: 21251552] - Vassilis Filiopoulos, Ioannis Koutis, Sofia Trompouki, Dimitrios Hadjiyannakos, Dimitrios Lazarou, Dimosthenis Vlassopoulos. Lanthanum carbonate versus sevelamer hydrochloride: improvement of metabolic acidosis and hyperkalemia in hemodialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
2011 Feb; 15(1):20-7. doi:
10.1111/j.1744-9987.2010.00868.x. [PMID: 21272248] - Angela Yee-Moon Wang. Vascular and valvular calcification in chronic peritoneal dialysis patients.
International journal of nephrology.
2011; 2011(?):198045. doi:
10.4061/2011/198045. [PMID: 21826268] - M Boaz, Z Katzir, D Schwartz, U Gafter, A Biro, L Shtendik, V Kon, G Chernin, T Weinstein. Effect of sevelamer hydrochloride exposure on carotid intima media thickness in hemodialysis patients.
Nephron. Clinical practice.
2011; 117(2):c83-8. doi:
10.1159/000319654. [PMID: 20714166] - Helmut Schiffl, Susanne M Lang. Phosphate binder is not phosphate binder! Sevelamer may be different!.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2011 Jan; 26(1):377-8; author reply 378. doi:
10.1093/ndt/gfq671. [PMID: 21059832] - Vasilis Tsimihodimos, Zoi Mitrogianni, Moses Elisaf. Dyslipidemia associated with chronic kidney disease.
The open cardiovascular medicine journal.
2011; 5(?):41-8. doi:
10.2174/1874192401105010041. [PMID: 21643500] - Lorenzo A Calò, Vincenzo Savica, Antonio Piccoli, Maria Fusaro, Angela D'Angelo, Paul A Davis. Reduction of hyperphosphatemia is related with the reduction of C-reactive protein in dialysis patients. Study in sevelamer-resistant dialysis patients treated with chitosan chewing gum as salivary phosphate binder.
Renal failure.
2011; 33(1):11-4. doi:
10.3109/0886022x.2010.528116. [PMID: 21219199] - Yu-Feng Lin, Chiang-Ting Chien, Wei-Chih Kan, Yung-Ming Chen, Tzong-Shinn Chu, Kuan-Yu Hung, Tun-Jun Tsai, Kwan-Dun Wu, Ming-Shiou Wu. Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: a randomized, open-label, parallel-group study.
Clinical drug investigation.
2011; 31(4):257-67. doi:
10.2165/11539120-000000000-00000. [PMID: 21299254] - Jalal Etemadi, Khosro Rahbar, Ali Nobakht Haghighi, Nazila Bagheri, Kianoosh Falaknazi, Mohammad Reza Ardalan, Kamyar Ghabili, Mohammadali M Shoja. Renal artery stenosis in kidney transplants: assessment of the risk factors.
Vascular health and risk management.
2011; 7(?):503-7. doi:
10.2147/vhrm.s19645. [PMID: 21915167] - Adrianne C Lebner, Kristin M Beard, Steven D Soroka, Serge H Cournoyer, Gerald A Da Roza, Denis F Geary, David C Mendelssohn. Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2011 Jan; 26(1):156-63. doi:
10.1093/ndt/gfq459. [PMID: 20667990] - Ana L E Cancela, Rodrigo B Oliveira, Fabiana G Graciolli, Luciene M dos Reis, Fellype Barreto, Daniela V Barreto, Lilian Cuppari, Vanda Jorgetti, Aluizio B Carvalho, Maria Eugênia Canziani, Rosa M A Moysés. Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Nephron. Clinical practice.
2011; 117(1):c74-82. doi:
10.1159/000319650. [PMID: 20689328] - M Salgueira, A I Martínez, J A Milán. Regression of vascular calcification in a patient treated with cinacalcet: a case report.
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
2011; 31(5):602-6. doi:
10.3265/nefrologia.pre2011.may.10869. [PMID: 21959728] - Mario Cozzolino, Florjan Mehmeti, Paola Ciceri, Elisa Volpi, Andrea Stucchi, Irene Brenna, Daniele Cusi. The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH Control.
International journal of nephrology.
2011; 2011(?):269060. doi:
10.4061/2011/269060. [PMID: 21603158] - Rafał Zwiech, Przemysław Dryja, Dominik Łacina, Violetta Króliczak, Sławomir Chrul, Feliks Kacprzyk. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
Wiadomosci lekarskie (Warsaw, Poland : 1960).
2011; 64(1):9-14. doi:
. [PMID: 21812357] - Markus Ketteler. Phosphate Metabolism in CKD Stages 3-5: Dietary and Pharmacological Control.
International journal of nephrology.
2011; 2011(?):970245. doi:
10.4061/2011/970245. [PMID: 21660261] - Katherine Wesseling-Perry, Renata C Pereira, Shobha Sahney, Barbara Gales, He-Jing Wang, Robert Elashoff, Harald Jüppner, Isidro B Salusky. Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.
Kidney international.
2011 Jan; 79(1):112-9. doi:
10.1038/ki.2010.352. [PMID: 20861820] - Cai-Mei Zheng, Kuo-Cheng Lu, Chia-Chao Wu, Yung-Ho Hsu, Yuh-Feng Lin. Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification.
International journal of nephrology.
2011; 2011(?):939613. doi:
10.4061/2011/939613. [PMID: 21660259] - Piergiorgio Bolasco. Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients.
International journal of nephrology.
2011; 2011(?):758450. doi:
10.4061/2011/758450. [PMID: 21716706] - Jeffrey A Kraut, Nicolaos E Madias. Consequences and therapy of the metabolic acidosis of chronic kidney disease.
Pediatric nephrology (Berlin, Germany).
2011 Jan; 26(1):19-28. doi:
10.1007/s00467-010-1564-4. [PMID: 20526632] - S Spaia. Phosphate binders: Sevelamer in the prevention and treatment of hyperphosphataemia in chronic renal failure.
Hippokratia.
2011 Jan; 15(Suppl 1):22-6. doi:
NULL. [PMID: 21897754] - Minako Koike, Kosaku Nitta. [Chronic kidney disease and atherosclerosis].
Nihon rinsho. Japanese journal of clinical medicine.
2011 Jan; 69(1):144-50. doi:
NULL. [PMID: 21226275] - Emanuel Zitt, Christine Jäger, Alexander R Rosenkranz, Manfred Eigner, Katharina Kodras, Josef Kovarik, Helmut Graf, Frank Pétavy, Sabine Horn, Bruno Watschinger. Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.
Wiener klinische Wochenschrift.
2011 Jan; 123(1-2):45-52. doi:
10.1007/s00508-010-1515-x. [PMID: 21253777] - Antonio Bellasi, Emiliana Ferramosca, Carlo Ratti. Arterial stiffness in chronic kidney disease: the usefulness of a marker of vascular damage.
International journal of nephrology.
2011; 2011(?):734832. doi:
10.4061/2011/734832. [PMID: 21660313] - Fahad Saeed, Nikhil Agrawal, Eugene Greenberg, Jean L Holley. Lower gastrointestinal bleeding in chronic hemodialysis patients.
International journal of nephrology.
2011; 2011(?):272535. doi:
10.4061/2011/272535. [PMID: 22007297] - Stephen J P Damment. Pharmacology of the phosphate binder, lanthanum carbonate.
Renal failure.
2011; 33(2):217-24. doi:
10.3109/0886022x.2011.552821. [PMID: 21332344] - Nicholas New, Janaki Mohandas, George T John, Sharad Ratanjee, Helen Healy, Leo Francis, Dwarakanathan Ranganathan. Calcific uremic arteriolopathy in peritoneal dialysis populations.
International journal of nephrology.
2011; 2011(?):982854. doi:
10.4061/2011/982854. [PMID: 21748002] - Peter Stenvinkel. Inflammation as a target for improving health in chronic kidney disease.
F1000 medicine reports.
2010 Dec; 2(?):88. doi:
10.3410/m2-88. [PMID: 21283598] - Ashima Gulati, Vijesh Sridhar, Tathagata Bose, Pankaj Hari, Arvind Bagga. Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4.
International urology and nephrology.
2010 Dec; 42(4):1055-62. doi:
10.1007/s11255-009-9688-9. [PMID: 20020207] - Theresa I Shireman, Ammar Almehmi, James B Wetmore, John Lu, Mark Pregenzer, L Darryl Quarles. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2010 Dec; 56(6):1108-16. doi:
10.1053/j.ajkd.2010.07.012. [PMID: 20951487] - Angel L M de Francisco, Michael Leidig, Adrian C Covic, Markus Ketteler, Ewa Benedyk-Lorens, Gabriel M Mircescu, Caecilia Scholz, Pedro Ponce, Jutta Passlick-Deetjen. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2010 Nov; 25(11):3707-17. doi:
10.1093/ndt/gfq292. [PMID: 20530499] - Patrick Biggar, Markus Ketteler. Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III - V).
Expert opinion on pharmacotherapy.
2010 Nov; 11(16):2739-50. doi:
10.1517/14656566.2010.526107. [PMID: 20977406] - Masahiro Koizumi, Masafumi Fukagawa. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Clinical calcium.
2010 Nov; 20(11):1700-8. doi:
clica101117001708. [PMID: 21037391] - Armando L Negri. Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?.
Journal of nephrology.
2010 Nov; 23(6):653-7. doi:
NULL. [PMID: 20349415] - María Dolores Arenas, Pablo Rebollo, Tamara Malek, Analia Moledous, M Teresa Gil, Fernando Alvarez-Ude, Ana Morales, Eva Cotilla. A comparative study of 2 new phosphate binders (sevelamer and lanthanum carbonate) in routine clinical practice.
Journal of nephrology.
2010 Nov; 23(6):683-92. doi:
NULL. [PMID: 20540040] - Harald Jüppner, Myles Wolf, Isidro B Salusky. FGF-23: More than a regulator of renal phosphate handling?.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2010 Oct; 25(10):2091-7. doi:
10.1002/jbmr.170. [PMID: 20593414]